Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 1.061.551.662.512.49

What is the latest Sales/Fixed Asset ratio of GLAND PHARMA ?

The latest Sales/Fixed Asset ratio of GLAND PHARMA is 1.06 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20251.06
Mar20241.55
Mar20231.66
Mar20222.51
Mar20212.49

How is Sales/Fixed Asset of GLAND PHARMA Trending?

Years Sales/Fixed Asset % Change
Mar2025 1.06
-31.61
Mar2024 1.55
-6.63
Mar2023 1.66
-33.86
Mar2022 2.51
0.80
Mar2021 2.49 -

Other Financial Ratios of GLAND PHARMA


Compare Sales/Fixed Asset ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,373.6 Cr 0.5% 2.1% 17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.5%

2.1%

17.9%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses